D
NeuroSense Therapeutics Ltd. NRSN
$1.14 -$0.0301-2.57% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 12/31/2024 06/30/2024 09/30/2023
Total Cash And Short-Term Investments -44.87% 27.95% -82.96% -43.64%
Total Receivables 125.27% -1.20% -13.36% -27.29%
Inventory -- -- -- --
Prepaid Expenses -- 24.29% -- --
Finance Division Loans and Leases Current -- -- -- --
Total Finance Division Other Current Assets -- -- -- --
Other Current Assets 22.86% -12.50% -7.89% 60.87%
Total Current Assets -3.89% 50.96% -78.59% -42.59%

Total Current Assets -3.89% 50.96% -78.59% -42.59%
Net Property, Plant & Equipment -47.50% -39.27% -29.58% -14.47%
Long-term Investments -- -- -- --
Goodwill -- -- -- --
Total Other Intangibles -- -- -- --
Finance Div Loans & Leases LT -- -- -- --
Total Finance Div Other LT Assets -- -- -- --
Total Other Assets 4.55% 4.55% -4.35% -38.24%
Total Assets -8.53% 43.64% -76.60% -41.65%

Total Accounts Payable -26.30% -20.49% 36.06% 343.20%
Total Accrued Expenses -- -60.69% -- --
Short-term Debt -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- --
Finance Division Debt Current -- 5.80% -- --
Total Finance Division Other Current Liabilities -45.19% -- 5.74% --
Total Other Current Liabilities -45.19% -- 5.74% --
Total Current Liabilities -37.20% -42.41% 16.74% 246.36%

Total Current Liabilities -37.20% -42.41% 16.74% 246.36%
Long-Term Debt -- -- -- --
Short-term Debt -- -- -- --
Capital Leases -- -- -65.38% -51.45%
Finance Division Debt Non Current -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- --
Total Other Liabilities -- -- -- 572.25%
Total Liabilities -37.84% -59.71% -62.35% 303.32%

Common Stock & APIC 33.15% 61.08% 8.20% 13.49%
Retained Earnings -27.75% -40.35% -8.30% -65.09%
Treasury Stock & Other -- -- -- --
Total Common Equity 69.52% 246.84% -10.23% -102.50%

Preferred Stock Redeemable -- -- -- --
Preferred Stock Non Redeemable -- -- -- --
Preferred Stock Convertible -- -- -- --
Preferred Stock, Others -- -- -- --
Total Preferred Equity -- -- -- --

Total Common Equity 69.52% 246.84% -10.23% -102.50%
Total Preferred Equity -- -- -- --
Total Minority Interest -- -- -- --
Total Equity 69.52% 246.84% -10.23% -102.50%